Hamid Reza Rahimi - Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Majid Mojarad - Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Meysam Moghbeli - Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Cancer has been always considered as one of the main human health challenges worldwide. One of the main causes of cancer-related mortality is late diagnosis in the advanced stages of the disease, which reduces the therapeutic efficiency. Therefore, novel non-invasive diagnostic methods are required for the early detection of tumors and improving the quality of life and survival in cancer patients. MicroRNAs (miRNAs) have pivotal roles in various cellular processes such as cell proliferation, motility, and neoplastic transformation. Since circulating miRNAs have high stability in body fluids, they can be suggested as efficient noninvasive tumor markers. MiR-۹۶ belongs to the miR-۱۸۳-۹۶-۱۸۲ cluster that regulates cell migration and tumor progression as an oncogene or tumor suppressor by targeting various genes in solid tumors. In the present review, we have summarized all of the studies that assessed the role of miR-۹۶ during tumor progression. This review clarifies the molecular mechanisms and target genes recruited by miR-۹۶ to regulate tumor progression and metastasis. It was observed that miR-۹۶ mainly affects tumorigenesis by targeting the structural proteins and FOXO transcription factors.

Cancer, Diagnosis, MicroRNA, miR-۹۶, Prognosis